Intrinsic 5-lipoxygenase activity regulates migration and adherence of mantle cell lymphoma cells.

Prostaglandins & Other Lipid Mediators
Chuanyou XiaHans-Erik Claesson

Abstract

Human B-lymphocytes express 5-lipoxygenase (5-LOX) and 5-LOX activating protein (FLAP) and can convert arachidonic acid to leukotriene B4. Mantle cell lymphoma (MCL) cells contain similar amounts of 5-LOX as human neutrophils but the function and mechanism of activation of 5-LOX in MCL cells, and in normal B-lymphocytes, are unclear. Here we show that the intrinsic 5-LOX pathway in the MCL cell line JeKo-1 has an essential role in migration and adherence of the cells, which are important pathophysiological characteristics of B-cell lymphoma. Incubation of JeKo-1 with the FLAP inhibitor GSK2190915 or the 5-LOX inhibitor zileuton, at a concentration below 1 μM, prior to stimulation with the chemotactic agent CXCL12, led to a significant reduction of migration. CRISPR/Cas9 mediated deletion of ALOX5 gene in JeKo-1 cells also led to a significantly decreased migration of the cells. Furthermore, 5-LOX and FLAP inhibitors markedly decreased the adherence of JeKo-1 cells to stromal cells. In comparison, these drugs had a similar effect on adherence of JeKo-1 cells as the Bruton tyrosine kinase inhibitor ibrutinib, which has a proven anti-tumour effect. These results indicate that inhibition of 5-LOX may be a novel treatment for MCL an...Continue Reading

References

Apr 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·P J JakobssonB Samuelsson
Apr 1, 1992·International Journal of Immunopharmacology·H E ClaessonP J Jakobsson
Jul 15, 1991·Biochemical and Biophysical Research Communications·P J JakobssonH E Claesson
Aug 15, 1995·European Journal of Biochemistry·P J JakobssonH E Claesson
Aug 16, 1994·Proceedings of the National Academy of Sciences of the United States of America·D M GuidotJ E Repine
Mar 3, 1999·Proceedings of the National Academy of Sciences of the United States of America·P ProvostO Rådmark
Apr 17, 1999·Journal of Internal Medicine·H E Claesson, S E Dahlén
Sep 2, 2003·Nature Immunology·Andrew M TagerAndrew D Luster
Sep 2, 2003·Nature Immunology·Katayoon GoodarziUlrich H von Andrian
Apr 1, 2006·Biochimica Et Biophysica Acta·Ming LuoThomas G Brock
Nov 3, 2007·European Journal of Haematology·Gudmundur RunarssonHans-Erik Claesson
Jan 13, 2009·BMC Immunology·Yilmaz MahshidHans-Erik Claesson
Apr 7, 2009·Molecular & Cellular Proteomics : MCP·Robert S BoydKelvin Cain
Jun 21, 2013·The New England Journal of Medicine·John C ByrdSusan O'Brien
Dec 18, 2013·Pulmonary Pharmacology & Therapeutics·R ChaudhuriN C Thomson
Aug 26, 2014·Biochimica Et Biophysica Acta·Olof RådmarkBengt Samuelsson
Jul 27, 2015·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Yilmaz MahshidHans-Erik Claesson
Oct 28, 2016·Cancer Research·Yaoyu ChenShaoguang Li
Apr 2, 2019·Prostaglandins & Other Lipid Mediators·Ann-Kathrin HäfnerDieter Steinhilber
Feb 12, 2021·Blood Advances·Sigrid S Skånland, Anthony R Mato

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

Related Papers

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
H ManevT Qu
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Laleh G MelstromThomas E Adrian
© 2021 Meta ULC. All rights reserved